KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Travere Therapeutics (TVTX) Receivables Refunds (2019 - 2021)

Travere Therapeutics (TVTX) has disclosed Receivables Refunds for 3 consecutive years, with $247000.0 as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Receivables Refunds fell 98.56% year-over-year to $247000.0, compared with a TTM value of $247000.0 through Dec 2021, down 98.56%, and an annual FY2021 reading of $247000.0, down 98.56% over the prior year.
  • Receivables Refunds was $247000.0 for Q4 2021 at Travere Therapeutics, down from $405000.0 in the prior quarter.
  • Across five years, Receivables Refunds topped out at $20.2 million in Q1 2020 and bottomed at $247000.0 in Q4 2021.
  • Average Receivables Refunds over 3 years is $10.1 million, with a median of $13.6 million recorded in 2020.
  • The sharpest move saw Receivables Refunds surged 1128.82% in 2020, then plummeted 98.56% in 2021.
  • Year by year, Receivables Refunds stood at $1.4 million in 2019, then soared by 1128.82% to $17.1 million in 2020, then tumbled by 98.56% to $247000.0 in 2021.
  • Business Quant data shows Receivables Refunds for TVTX at $247000.0 in Q4 2021, $405000.0 in Q3 2021, and $400000.0 in Q2 2021.